Dexcom G7 CGM & t:slim X2 Pump Integration

The #1 rated t:slim X2¹ is the first insulin pump in the U.S. to integrate with the Dexcom G7 continuous glucose monitoring (CGM) sensor.*

Trusted Partners

More than 10 years of collaboration between Tandem Diabetes Care and Dexcom.

No Fingersticks

For calibration or mealtime dosing, when the t:slim X2 insulin pump is integrated with Dexcom G7.^†

Faster Warmup

Spend more time in closed loop with shorter wait times between sessions.^‡

10-Day Sensor Wear

Plus an additional 12-hour grace period after the sensor has expired.

Control-IQ Technology

The t:slim X2 insulin pump with Control-IQ technology, when paired with a compatible CGM sensor, can create an automated insulin delivery system (AID) that predicts and helps prevent highs and lows.

Learn More

What's next?

Whether you're ready to get a Tandem insulin pump, or looking to check insurance coverage, you’ll find everything you need here.

Get Started

Existing Tandem Pump Users

Update Your Pump Software

Users with an in-warranty t:slim X2 insulin pump can update their pump software to integrate with a Dexcom G7 sensor.^§

Check Sensor Compatibility

Already have a Dexcom G7 sensor? Before updating, review a breakdown of what versions are compatible with your pump.

Check Now

Complete Required Steps

You may need to complete required training or other steps to receive your Update ID Number. Log in to your account for details.

Responsible Use of Control‑IQ Technology

Even with advanced systems such as Control-IQ technology, you are still responsible for actively managing your diabetes. Control-IQ technology does not prevent all high and low blood glucose events. The system is designed to help reduce glucose variability, but it requires your accurate input of information, such as meals and periods of sleep or exercise. Control-IQ technology will not function as intended unless you use all system components, including your CGM, infusion sets and pump cartridges, as instructed. Importantly, the system cannot adjust your insulin dosing if the pump is not receiving CGM readings. Because there are situations and emergencies that the system may not be capable of identifying or addressing, always pay attention to your symptoms and treat according to your healthcare provider’s recommendations.

* CGM sold separately.

† If glucose alerts and Dexcom CGM readings do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.

‡ Faster claim based on 2 hour warmup time with the Dexcom G6 sensor vs. 30 minute warmup time with the Dexcom G7 sensor.

§ Additional feature updates may not be currently available for the t:slim X2 insulin pump with Control-IQ technology. Control-IQ technology is available only to customers who reside in the United States or Canada, and other select geographies. Future updates for all or some of Tandem’s products may not be developed and may not be offered everywhere and would be subject to applicable regulatory approvals. Software updates are only available to customers who are in warranty at the time they update their pump. Additional training may be required to access certain future software updates. Charges may apply. Tandem may discontinue select software and features over time at its discretion.

References
1. dQ&A US Patient Panel Q3 2023 (July-Sept. 2023)

Important Safety Information

RX ONLY. The t:slim X2 pump and Control-IQ technology are intended for single patient use. The t:slim X2 pump and Control-IQ technology are indicated for use with NovoLog or Humalog U-100 insulin.

t:slim X2 insulin pump: The t:slim X2 insulin pump with interoperable technology is an alternate controller enabled (ACE) pump that is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The t:slim X2 pump is indicated for use in individuals six years of age and greater. Control-IQ technology: Control-IQ technology is intended for use with a compatible integrated continuous glucose monitor (iCGM, sold separately) and ACE pump to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ technology is intended for the management of Type 1 diabetes mellitus in persons six years of age and greater.

WARNING: Control-IQ technology should not be used by anyone under the age of six years old. It should also not be used in patients who require less than 10 units of insulin per day or who weigh less than 55 pounds.

Control-IQ technology is not indicated for use in pregnant women, people on dialysis, or critically ill patients. Do not use Control-IQ technology if using hydroxyurea. Users of the t:slim X2 pump and Control-IQ technology must: use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders. The t:slim X2 pump and the CGM transmitter and sensor must be removed before MRI, CT, or diathermy treatment. Visit www.tandemdiabetes.com/safetyinfo for additional important safety information.

Dexcom Brief Safety Statement

Failure to use the Dexcom Continuous Glucose Monitoring System and its components according to the instructions for use provided with your device and available at dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the Dexcom CGM do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.

t:slim X2 Insulin Pump Dexcom G7 Integration